THIS MONTH’S ISSUE

Read, save, and print articles from the current issue

ARTICLES

Chronological index
2013–2017

PRODUCT GUIDES

Compare all instruments
and software systems

DEPARTMENTS

Chronological index
2013–2017

WEBINARS

Register Now and
On Demand

Home » Top news

FDA clears Panther Fusion Flu A/B/RSV assay

Oct. 12, 2017Hologic has received 510(k) clearance from the FDA for its Panther Fusion Flu A/B/RSV assay for use on its Panther Fusion system.

The Panther Fusion is available as a full system or as a module that can be attached to existing Panther systems. The Panther Fusion is capable of running polymerase chain reaction assays in addition to tests based on transcription-mediated amplification.

“Hologic has long-standing expertise in flu extending back to the introduction of ProFlu+, the first FDA-cleared Flu A/B/RSV assay on the market in 2008,” Tom West, president of the Diagnostic Solutions Division, Hologic, said in a statement. “This expertise has translated to the development of a test with excellent performance, and that test is now available on our integrated platform, which fully automates all aspects of testing, from sample to result.”

More top news

Print Friendly, PDF & Email
Tags:

X